Cancer News
LYMPHEDEMA SCREENING, TREATMENT IMPROVE QUALITY OF LIFE IN BREAST CANCER PATIENTS
Advances in medicine have increased the number of breast cancer survivors. Now, physicians like Lisa Spiguel, M.D., are turning their attention toward what happens after beating cancer—aka, the rest of your life.
GENETIC MUTATION COULD PLAY ROLE IN IMPROVING LEUKEMIA TREATMENT, UF HEALTH RESEARCHERS FIND
In the battle against one type of leukemia, a genetic mutation could hold the key to more effective, lower-dose treatments. The new, early findings by University of Florida Health researchers and their colleagues are especially relevant for older or frail patients who may not be able to tolerate high-dose chemotherapy.
NEW LINEAR ACCELERATOR AT UF VETERINARY COLLEGE ENHANCES CANCER TREATMENT FOR ANIMALS
A 9-year-old dog named Lincoln, diagnosed with a tumor deep inside his chest that threatened his heart, is doing well at home in Orlando and back to counter-surfing for treats after completing a month of radiation therapy at UF’s College of Veterinary Medicine, becoming one of the first patients to be treated using a new linear accelerator, or LINAC, now available to animal patients at UF.
A NEW WAVE OF MEDICINE: ANSWER THE CALL
The ocean is calling and beneath its surface dwells an unseen power to heal. Dr. Hendrik Luesch explores the world’s oceans in search of natural compounds that treat cancer and other deadly diseases. In these uncharted waters, lies new chemistry, new biology and new cures just waiting to be revealed. His discoveries have already provided the basis for various FDA-approved cancer treatments and new starting points to treat pancreatic, colon, breast and ovarian cancers, as well as ocular and autoimmune diseases. He is also working on the development of broad-spectrum antivirals to combat COVID-19 and future pandemics.
Play Video
DRIVING EQUITY & INCLUSION IN CANCER CARE: A Q&A WITH DR. RAYMOND MAILHOT
Raymond Mailhot, M.D., dedicates his research to improving radiation treatment. He cares for pediatric patients and patients with breast cancer, and he leads the hematology malignancy radiotherapy program. In this Q&A, Dr. Mailhot shares how he’s working to accelerate equity in cancer care and reflects on personal experiences with structural racism in oncology.
PANCREATIC ENZYME REPLACEMENT THERAPY IMPROVES PATIENT QUALITY OF LIFE, RECOVERY
A healthy pancreas stays behind the scenes, creating digestive enzymes that convert food into nutrition that your body needs to keep it running smoothly. But in patients diagnosed with pancreatic diseases, the organ falls short, and a host of unwelcome side effects can occur.
SCOPE OF TREATMENT SEQUENCING GROWS IN GENITOURINARY MALIGNANCIES
Checkpoint inhibitors have become staples of frontline and maintenance treatment for patients with metastatic renal cell carcinoma (mRCC) and advanced urothelial cancer, respectively, said Jonathan A. Chatzkel, MD, who added that the initial excitement seen with immunotherapy in those settings is now being seen with the second- and third-line use of antibody-drug conjugates (ADCs) and FGFR inhibitors in urothelial cancer.
